Minirin (Desmopressin Acetate)

Desmopressin acetate, the active ingredient in Minirin, is a vasopressin analog presented as a nasal spray for nasal use. It treats central diabetes insipidus and nocturnal enuresis in appropriate patients.

GNH USA supplies Minirin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Desmopressin acetate is used to manage disorders of water balance that involve antidiuretic hormone deficiency or dysfunction.

- Central diabetes insipidus: reduces excessive urine output and helps maintain normal fluid balance. - Nocturnal enuresis: decreases nighttime urine production, reducing bedwetting episodes.

Desmopressin acetate may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Nasal irritation or congestion: mild discomfort at the site of administration. - Headache: transient, often resolves without intervention. - Mild hyponatraemia: low serum sodium, usually asymptomatic. - Nausea or abdominal cramps: gastrointestinal discomfort. - Increased thirst: sensation of dry mouth.

Serious or Rare Side Effects: - Severe hyponatraemia: can lead to seizures, coma, or death. - Water intoxication: excessive fluid retention causing edema. - Allergic reaction: rash, itching, swelling, or anaphylaxis. - Nasal septum perforation: rare structural damage with prolonged use. - Hypertension exacerbation: elevated blood pressure in susceptible individuals.

Before using Desmopressin acetate, consider the following safety measures.

- Monitor serum sodium: check electrolytes regularly, especially in the elderly or those on diuretics. - Adjust dose in renal impairment: reduced clearance may increase risk of hyponatraemia. - Use caution in hepatic disease: impaired metabolism can alter drug levels. - Avoid in uncontrolled hypertension: fluid retention may worsen blood pressure. - Discontinue if signs of water intoxication appear: such as sudden weight gain, edema, or confusion. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Desmopressin acetate can interact with several medicines, affecting its safety or efficacy.

Major Interactions (Avoid): - NSAIDs (e.g., ibuprofen, naproxen): increase risk of hyponatraemia. - Thiazide diuretics: potentiate water retention and hyponatraemia. - Carbamazepine: accelerates desmopressin clearance, reducing effectiveness.

Moderate Interactions (Monitor Closely): - Antihypertensives (e.g., ACE inhibitors): may enhance fluid‑retaining effects. - Estrogen‑containing therapies: can increase desmopressin activity, requiring sodium monitoring.